U.S. market Closed. Opens in 7 hours 47 minutes

ACIU | AC Immune SA Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue14.80M3.94MN/A15.43M111.03M7.19M20.25M23.21M39.09M30.27M
Cost of Revenue54.61M60.34M62.28M59.49M50.43MN/AN/AN/AN/AN/A
Gross Profit-39.80M-56.40M-62.28M-44.06M60.59M7.19MN/AN/AN/AN/A
Operating Expenses68.42M74.78M79.01M76.69M66.49M56.74M42.79M33.67M20.47M19.55M
Selling, General & Admin10.58M15.79M10.88M11.09M9.42M7.56M6.27M4.73M2.04M2.00M
Research & Development54.61M60.34M62.28M59.49M50.43M44.28M32.66M25.77M17.05M16.12M
Other Operating Expenses3.24M-1.34M5.85M6.12M6.64M4.90M3.86M3.17M1.38M1.44M
Operating Income-53.62M-70.85M-79.01M-61.26M44.54M-49.55M-22.54M-10.46M18.62M10.72M
Other Expenses / Income-1.47M107.00K6.02M-661.00K906.00K-1.19M-3.87M3.36M1.65M27.00K
Before Tax Income-54.22M-70.74M-72.99M-61.92M45.44M-50.95M-26.41M-7.10M20.27M10.74M
Income Tax Expenses10.00K13.00K3.00K184.00K1.89M-1.10MN/AN/AN/AN/A
Net Income-54.23M-70.75M-73.00M-62.10M45.44M-50.95M-26.41M-7.10M20.27M10.74M
Interest Expenses176.00K355.00K581.00K184.00K1.89M298.00K147.00K256.00K26.00K4.00K
Basic Shares Outstanding84.69M83.55M74.95M71.90M70.60M61.84M57.08M50.10M43.41M55.40M
Diluted Shares Outstanding84.69M83.55M74.95M71.90M71.10M61.84M57.08M50.10M46.04M55.40M
EBITDA-50.37M-70.78M-70.12M-59.22M46.50M-48.50M-25.68M-6.56M20.58M11.05M
EBITDA Margin-340.28%-1,798.68%0.00%-383.74%41.88%-674.15%-126.80%-28.27%52.66%36.49%
EBIT-54.05M-70.39M-72.41M-61.74M49.23M-51.76M-26.26M-6.84M20.30M10.75M
EBIT Margin-365.16%-1,788.69%0.00%-400.08%44.34%-719.43%-129.67%-29.46%51.92%35.51%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙